Global Lung Stents Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Self-Expandable Stents , Non-Expandable Stents and Balloon-Expandable Stents.By Material;
Metal Lung Stents - Nitinol Lung Stents, Stainless Steel Lung Stents and Other Metal Lung Stents, Silicone Lung Stents and Hybrid Lung Stents.By Procedure;
Bronchoscopy - Flexible Bronchoscopy and Rigid Bronchoscopy, Laryngoscopy.By End Users;
Hospitals , Ambulatory Surgery Centers and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Lung Stents Market (USD Million), 2021 - 2031
In the year 2024, the Global Lung Stents Market was valued at USD 7,621.82 million. The size of this market is expected to increase to USD 12,048.10 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.
The global lung stents market is experiencing significant growth, driven by an increasing prevalence of respiratory diseases and advancements in medical technology. Lung stents, which are used to keep the airways open in patients suffering from conditions such as tracheal stenosis, lung cancer, and chronic obstructive pulmonary disease (COPD), have become crucial in pulmonary care. As these conditions become more common worldwide due to factors like aging populations, pollution, and smoking, the demand for effective and minimally invasive treatment options is rising, thus boosting the lung stents market.
Technological advancements have played a pivotal role in enhancing the effectiveness and safety of lung stents. Innovations such as drug-eluting stents, which release medication to prevent scar tissue formation, and biodegradable stents, which gradually dissolve after serving their purpose, are setting new standards in patient care. These innovations are not only improving patient outcomes but also expanding the potential applications of lung stents. Moreover, the integration of advanced imaging techniques with stenting procedures has improved the precision of stent placements, further driving market growth.
Geographically, the lung stents market is witnessing varied growth patterns. North America and Europe currently dominate the market, attributable to their advanced healthcare infrastructure, high awareness among patients and healthcare providers, and significant investments in research and development. However, emerging economies in Asia-Pacific, Latin America, and the Middle East are poised for substantial growth. Increasing healthcare expenditure, growing awareness about advanced medical treatments, and improving healthcare infrastructure in these regions are contributing to the market's expansion.
The competitive landscape of the global lung stents market is characterized by the presence of several key players striving to enhance their product offerings and market reach. Companies are engaging in strategic partnerships, mergers, and acquisitions to strengthen their market position and expand their product portfolios. Additionally, there is a strong focus on research and development activities aimed at introducing innovative stent designs and materials. This competitive environment is fostering innovation and pushing the boundaries of what is possible in pulmonary care, ultimately benefiting patients with more effective and safer treatment options.
Global Lung Stents Market Recent Developments
- January 2020, the U.S. FDA approved a 3D-printed airway stent designed to fit a patient’s airway. Conducted by the Cleveland Clinic, the study estimated that around 30,000 stents would be implanted in the U.S. by the end of 2020, indicating a significant potential demand for lung stents in the near future.
- June 2018, Taewoong Medical (South Korea) partnered with Cook Medical (US) to distribute Taewoong's product portfolio in the US market.
- May 2018, Merit Medical Systems, Inc. (US) entered into a worldwide distribution agreement with NinePoint Medical, Inc. (US) to market Merit's gastrointestinal and pulmonary medical devices.
- July 2015, Micro-Tech (Nanjing) Co., Ltd. established a wholly-owned subsidiary in the US, Micro-Tech USA, Inc.
Segment Analysis
The global lung stents market has witnessed substantial growth in recent years, driven by several factors such as increasing prevalence of respiratory disorders, advancements in medical technology, and a growing geriatric population. Lung stents, also known as bronchial or tracheal stents, are medical devices used to open up blocked airways, providing relief to patients suffering from conditions like chronic obstructive pulmonary disease (COPD), lung cancer, and pneumonia. As the incidence of these respiratory diseases continues to rise, particularly in developing regions with high levels of air pollution and smoking prevalence, the demand for lung stents is expected to escalate further.
Technological innovations in stent design and materials have led to the development of more effective and durable products, enhancing patient outcomes and reducing the need for repeat interventions. These advancements include the introduction of drug-eluting stents, which release medications to prevent restenosis and improve long-term efficacy. Additionally, the shift towards minimally invasive procedures has increased the adoption of lung stents, as they offer a less invasive alternative to traditional surgical interventions, resulting in shorter hospital stays and quicker recovery times for patients.
The market growth may be hindered by factors such as stringent regulatory requirements for medical devices and the high cost associated with stent implantation procedures. Furthermore, the lack of awareness among patients and healthcare professionals about the benefits of lung stents in treating respiratory conditions could also pose a challenge to market expansion. Nonetheless, strategic collaborations between medical device companies and healthcare providers, along with initiatives to educate both patients and physicians, are anticipated to drive the adoption of lung stents and fuel market growth in the coming years.
Global Lung Stents Segment Analysis
In this report, the Global Lung Stents Market has been segmented by Product, Material, Procedure, End Users and Geography.
Global Lung Stents Market, Segmentation by Product
The Global Lung Stents Market has been segmented by Product into Self-Expandable Stents , Non-Expandable Stents and Balloon-Expandable Stents.
The global lung stents market is experiencing significant growth, driven by advancements in medical technology and an increasing prevalence of respiratory disorders worldwide. One of the key factors contributing to this growth is the segmentation of the market based on product types. The market is segmented into self-expandable stents, non-expandable stents, and balloon-expandable stents, each catering to specific patient needs and medical requirements.
Self-expandable stents are designed to expand automatically once inserted into the targeted area of the lung, providing support and maintaining airway patency. They are often preferred for their ease of deployment and ability to conform to the anatomy of the airways. Non-expandable stents, on the other hand, are typically made of rigid materials and are used in cases where precise positioning is required or when there is a risk of stent migration.
Balloon-expandable stents are deployed using a balloon catheter, which is inflated to expand the stent to the desired diameter. These stents offer precise control during deployment and are often used in complex cases where other types of stents may not be suitable. The choice of stent type depends on various factors, including the patient's condition, the location and severity of the airway obstruction, and the physician's preference.
With the growing demand for minimally invasive procedures and the increasing prevalence of respiratory conditions such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma, the global lung stents market is expected to witness continued expansion in the coming years. Emerging economies, particularly in Asia-Pacific and Latin America, are also likely to offer lucrative opportunities for market players due to improving healthcare infrastructure and rising healthcare expenditure in these regions.
Global Lung Stents Market, Segmentation by Material
The Global Lung Stents Market has been segmented by Material into Metal Lung Stents , Silicone Lung Stents and Hybrid Lung Stents.
The global lung stents market has witnessed significant growth in recent years, primarily driven by advancements in medical technology and an increasing prevalence of respiratory diseases such as lung cancer and chronic obstructive pulmonary disease (COPD). One of the key factors contributing to this growth is the segmentation of lung stents by material, which offers healthcare providers and patients a range of options to address specific needs and preferences.
Metal lung stents have traditionally been the most commonly used type, owing to their durability and effectiveness in providing structural support to the airways. These stents are often made of materials like nitinol or stainless steel, offering strong mechanical properties and long-term stability within the respiratory system. However, concerns about complications such as stent migration and tissue overgrowth have led to the development of alternative materials.
Silicone lung stents have gained popularity due to their flexibility and biocompatibility. These stents are typically softer and more pliable than metal counterparts, allowing for easier insertion and reduced risk of tissue damage. Additionally, silicone stents can be customized to fit individual patient anatomy, providing a tailored solution for complex respiratory conditions.
Hybrid lung stents combine the advantages of both metal and silicone materials, offering a versatile option for clinicians and patients. These stents may feature a metal framework for structural support along with a silicone coating to enhance biocompatibility and reduce the risk of complications. By leveraging the strengths of multiple materials, hybrid lung stents aim to optimize clinical outcomes while minimizing potential drawbacks.
The segmentation of the global lung stents market by material reflects ongoing efforts to improve treatment options for respiratory diseases. Whether it's metal stents for robust support, silicone stents for flexibility, or hybrid solutions for a balanced approach, healthcare providers have access to a diverse range of products to meet the diverse needs of patients. As technology continues to advance, further innovations in materials and design are expected to drive continued growth and innovation in this critical area of medical care.
Global Lung Stents Market, Segmentation by Procedure
The Global Lung Stents Market has been segmented by Procedure into Bronchoscopy and Laryngoscopy.
The global lung stents market is witnessing significant growth, largely driven by advancements in medical technology and an increasing prevalence of respiratory disorders. One of the key factors contributing to this growth is the segmentation of the market by procedure. Bronchoscopy and laryngoscopy are two primary procedures that play a crucial role in the diagnosis and treatment of various lung conditions.
Bronchoscopy, which involves the insertion of a thin, flexible tube called a bronchoscope into the airways, allows for direct visualization of the lungs and air passages. It is commonly used for diagnosing conditions such as lung cancer, infections, and airway obstructions. Lung stents inserted during bronchoscopy procedures can help maintain airway patency and alleviate symptoms such as shortness of breath.
On the other hand, laryngoscopy focuses on the examination and treatment of the larynx, or voice box. This procedure is often used to diagnose and manage conditions affecting the upper airway, such as vocal cord paralysis, laryngeal tumors, and subglottic stenosis. Lung stents may be utilized in laryngoscopy procedures to support the airway and facilitate breathing in cases where there is narrowing or obstruction.
As healthcare providers increasingly adopt minimally invasive techniques for diagnosing and treating respiratory disorders, the demand for lung stents is expected to rise. These devices not only offer effective solutions for managing airway problems but also contribute to improved patient outcomes and quality of life. With ongoing research and development efforts aimed at enhancing the efficacy and safety of lung stents, the market is poised for further expansion in the coming years.
Global Lung Stents Market, Segmentation by End Users
The Global Lung Stents Market has been segmented by End Users into Hospitals , Ambulatory Surgery Centers and Others.
The global lung stents market is witnessing significant growth, primarily driven by advancements in medical technology and an increasing prevalence of respiratory disorders. One of the key factors contributing to this growth is the segmentation of the market by end users. Hospitals, ambulatory surgery centers, and other healthcare facilities constitute the primary end users of lung stents. These institutions are equipped with the necessary infrastructure and expertise to perform complex procedures related to respiratory health, thereby driving the demand for lung stents.
Another aspect of segmentation lies in the procedures for which lung stents are utilized. The market is divided based on procedures such as bronchoscopy and laryngoscopy. Bronchoscopy, in particular, is a widely performed procedure for diagnosing and treating various lung conditions, including tumors, infections, and obstructions. The use of lung stents in bronchoscopy procedures has become increasingly common, as they provide support and maintain airway patency, enhancing patient outcomes.
The global lung stents market is characterized by intense competition among key players striving to expand their market presence through product innovations and strategic collaborations. Manufacturers are focusing on developing stents with improved biocompatibility, durability, and ease of deployment to meet the evolving needs of healthcare professionals and patients. Additionally, initiatives aimed at raising awareness about respiratory disorders and the availability of advanced treatment options are expected to further fuel market growth.
The segmentation of the global lung stents market by end users and procedures underscores the diverse applications and growing adoption of these devices in respiratory care. With ongoing advancements in medical technology and a rising emphasis on personalized medicine, the market is poised for continued expansion in the foreseeable future.
Global Lung Stents Market, Segmentation by Geography
In this report, the Global Lung Stents Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Lung Stents Market Share (%), by Geographical Region, 2024
The global lung stents market is witnessing substantial growth, driven by factors such as increasing prevalence of respiratory disorders and advancements in minimally invasive procedures. This market has been segmented by geography into five key regions: North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America holds a significant share in the global lung stents market, attributed to well-established healthcare infrastructure, high adoption of advanced medical technologies, and increasing prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer. Additionally, supportive reimbursement policies and growing awareness regarding minimally invasive treatment options further contribute to the region's market dominance.
Europe follows North America in terms of market share, driven by the presence of key market players, rising geriatric population, and increasing investments in healthcare infrastructure. Moreover, initiatives aimed at promoting early diagnosis and treatment of respiratory disorders propel market growth in this region.
The Asia Pacific region is expected to witness rapid growth in the lung stents market due to factors such as increasing healthcare expenditure, rising prevalence of respiratory diseases, and expanding access to advanced medical treatments. Furthermore, growing awareness regarding the benefits of minimally invasive procedures and improving healthcare infrastructure contribute to market expansion in this region.
The Middle East and Africa, as well as Latin America, are also projected to experience significant growth in the lung stents market, driven by improving healthcare facilities, increasing prevalence of respiratory disorders, and rising investments in medical research and development. However, challenges such as limited access to healthcare services in remote areas may hinder market growth to some extent in these regions.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Lung Stents Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers
- Increasing COPD prevalence
- Aging population growth
- Technological advancements surge
- Rising healthcare expenditure
-
Growing smoking rates: The rising prevalence of smoking globally continues to be a significant contributor to respiratory ailments, including chronic obstructive pulmonary disease (COPD) and lung cancer. Despite widespread awareness campaigns and efforts to curb tobacco consumption, smoking rates have shown stubborn resilience, especially in certain regions where cultural factors or limited access to cessation resources perpetuate the habit. This persistent smoking trend not only poses a grave public health challenge but also fuels the demand for medical interventions to address the resulting respiratory conditions. As a consequence, the global market for lung stents, which are used in the treatment of conditions like COPD and lung cancer, is experiencing notable growth. This growth is driven not only by the increasing incidence of respiratory diseases but also by advancements in stent technology, enabling more effective and minimally invasive treatments for patients worldwide.
The global lung stents market is witnessing significant expansion, propelled by factors such as the aging population, the growing prevalence of respiratory disorders, and advancements in medical technology. Lung stents play a crucial role in managing various respiratory conditions, including airway obstruction caused by tumors, inflammation, or structural abnormalities. As healthcare systems strive to improve patient outcomes and reduce the burden of chronic respiratory diseases, the demand for innovative medical devices like lung stents continues to rise. Additionally, increasing investments in healthcare infrastructure, particularly in developing economies, further contribute to the growth of the lung stents market by expanding access to advanced medical treatments. Overall, with the convergence of demographic trends, technological advancements, and healthcare investments, the global lung stents market is poised for sustained growth in the coming years.
Restraints
- High treatment costs
- Limited product awareness
- Stringent regulatory policies
- Complications post-procedure risks
-
Insufficient reimbursement schemes: Insufficient reimbursement schemes pose a significant challenge to the growth of the global lung stents market. Lung stents are often used in the treatment of various respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and lung cancer. However, the high cost of these devices combined with inadequate reimbursement policies in many regions hampers their widespread adoption. Healthcare providers may be hesitant to prescribe lung stents if patients cannot afford them or if reimbursement rates are too low, leading to delays in treatment and suboptimal patient outcomes.
The lack of standardized reimbursement schemes across different countries adds another layer of complexity to the market. Variations in reimbursement policies and rates can create barriers to market entry for companies looking to expand their presence globally. To address these challenges, stakeholders in the lung stents market, including manufacturers, policymakers, and healthcare providers, need to collaborate to develop more equitable reimbursement strategies that ensure patients have access to these life-saving devices without undue financial burden. Additionally, efforts to streamline reimbursement processes and increase transparency can help drive market growth and improve patient access to essential respiratory care.
Opportunities
- Emerging markets potential
- Innovation in materials
- Growing telehealth adoption
- Expanding geriatric care
-
Increasing clinical trials: The global lung stents market has been witnessing a notable surge in clinical trials, driven by advancements in medical technology and a growing demand for innovative solutions in respiratory care. Lung stents, which are used to treat various respiratory conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and bronchial strictures, are undergoing extensive research and development to enhance their efficacy and safety profiles. These clinical trials encompass a spectrum of approaches, including evaluating new materials for stent fabrication, exploring minimally invasive insertion techniques, and assessing long-term patient outcomes. With the rising prevalence of respiratory disorders worldwide and an aging population, there is a pressing need to expand the evidence base for lung stent interventions through rigorous clinical investigation, paving the way for improved therapeutic options and better patient care.
The increasing clinical trials in the global lung stents market are fostering collaborations among healthcare institutions, medical device manufacturers, and research organizations to accelerate innovation and bring novel solutions to the forefront. This collaborative effort aims to address unmet clinical needs and overcome existing challenges in lung stent therapy, such as stent migration, tissue ingrowth, and stent-related complications. By leveraging multidisciplinary expertise and leveraging technological advancements such as advanced imaging modalities and biomaterial engineering, researchers are poised to develop next-generation lung stents that offer superior performance, durability, and biocompatibility. As these clinical trials progress and yield promising results, they are expected to drive the adoption of lung stent technologies globally, ultimately improving the quality of life for patients suffering from respiratory diseases.
Competitive Landscape Analysis
Key players in Global Lung Stents Market include:
- Boston Scientific
- C.R. Bard
- Taewoong Medical
- Micro-Tech (Nanjing)
- Teleflex
- Merit Medical Systems
- Cook Group
- Novatech Sa
- Endo-Flex
- M.I. Tech
- Efer Endoscopy
- Fuji Systems
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Material
- Market Snapshot, By Procedure
- Market Snapshot, By End Users
- Global Lung Stents Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing COPD prevalence
- Aging population growth
- Technological advancements surge
- Rising healthcare expenditure
- Growing smoking rates
- Restraints
- High treatment costs
- Limited product awareness
- Stringent regulatory policies
- Complications post-procedure risks
- Insufficient reimbursement schemes
- Opportunities
- Emerging markets potential
- Innovation in materials
- Growing telehealth adoption
- Expanding geriatric care
- Increasing clinical trials
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Lung Stents Market, By Product, 2021 - 2031 (USD Million)
- Self-Expandable Stents
- Non-Expandable Stents
- Balloon-Expandable Stents
- Global Lung Stents Market, By Material, 2021 - 2031(USD Million)
- Metal Lung Stents
- Nitinol Lung Stents
- Stainless Steel Lung Stents
- Other Metal Lung Stents
- Silicone Lung Stents
- Hybrid Lung Stents
- Metal Lung Stents
- Global Lung Stents Market, By Procedure, 2021 - 2031 (USD Million)
- Bronchoscopy
- Flexible Bronchoscopy
- Rigid Bronchoscopy
- Laryngoscopy
- Bronchoscopy
- Global Lung Stents Market, By End Users, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgery Centers
- Others
- Global Lung Stents Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Lung Stents Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Boston Scientific
- C.R. Bard
- Taewoong Medical
- Micro-Tech (Nanjing)
- Teleflex
- Merit Medical Systems
- Cook Group
- Novatech Sa
- Endo-Flex
- M.I. Tech
- Efer Endoscopy
- Fuji Systems
- Company Profiles
- Analyst Views
- Future Outlook of the Market